Population-based risks for cancer in patients with ALS.

Area of Science:

• Neurology
• Oncology
• Epidemiology

Background:

• Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease.
• Cancer risk in ALS patients requires further investigation.

Purpose of the Study:

• To estimate the overall and site-specific cancer risks in a cohort of patients diagnosed with amyotrophic lateral sclerosis (ALS).

Main Methods:

• An observational, longitudinal study utilizing the Utah Population Database, linked to cancer registry and death certificate data.
• Hazard ratios (HRs) were calculated comparing observed to expected cancer incidence in ALS patients.
• Cox regression was employed to adjust for shortened lifespan and estimate cancer risks.

Main Results:

• A significantly decreased overall cancer hazard was observed in ALS patients (HR 0.80).
• Reduced hazard for lung cancer (HR 0.23) and increased hazards for salivary (HR 5.27) and testicular cancers (HR 3.82) were identified.
• A non-significant trend towards increased risk for cutaneous malignant melanoma was noted.

Conclusions:

• The study indicates a significantly lower overall cancer risk in individuals with ALS, including lung cancer.
• Conversely, a significantly elevated risk for salivary and testicular cancers was observed in the ALS cohort.